Medical device packaging system

ABSTRACT

A system, comprising a sterilizable package; an implantable medical device placed inside the sterilizable package; and an electrical interface electrically coupled to the implantable medical device and extending from inside the sterilizable package to outside the sterilizable package. In various embodiments, the interface may include package contacts electrically coupled to electrode terminals on the implantable medical device, patient terminals and conductors extending between the package contacts and the patient terminals.

RELATED APPLICATION

This application is a divisional of U.S. patent application Ser. No.11/290,775, filed Nov. 30, 2005 entitled “MEDICAL DEVICE PACKAGINGSYSTEM”, herein incorporated by reference in its entirety.

TECHNICAL FIELD

The invention relates generally to implantable medical devices, and, inparticular, to configurations of implantable medical device packagingsystems.

BACKGROUND

Implantable medical devices (IMDs) such as cardiac pacemakers,implantable cardiovertor defibrillators (ICDs), implantable looprecorders (ILRs), implantable drug pumps, neurostimulators, etc. aregenerally provided by manufactures in a sterilized package. The packagecommonly includes an external carton or container for holding asterilized inner tray or pouch containing the IMD. The IMD is sterilizedwithin the inner tray or pouch using appropriate sterilization methodssuch as steam, gas or ultrasonic sterilization. The inner tray or pouchis generally provided with a peelable or tearable seal that can beopened to drop the sterile IMD contained therein into a sterile fieldwithout compromising the sterility of the IMD or the sterile field. Forexample, an IMD packaging tray having an open top may be sealed closedwith a paper lid that is peeled back at the time of an implant procedureto allow the IMD to be dropped out of the tray into the sterile field.

Some packaging systems may include within the external carton orcontainer an outer tray or pouch for carrying the sterilized inner trayor pouch. The inner tray or pouch and device contained therein may besterilized within the outer tray or pouch. The outer tray or pouch maythen be peeled open to drop the inner tray or pouch into the sterilefield at the time of implant. An implanting physician or assistant maythen open the inner tray or pouch within the sterile field.

Pre-implant testing, electrophysiological mapping, or system testing iscommonly performed at the beginning of an implantation procedure toensure that a patient meets implantation criteria and/or to determine anoptimal implant location for the IMD and/or associated electrodes. Suchtesting may be performed using the IMD since using the IMD itself wouldgenerally provide the most reliable test results. However, duringpre-implant testing, considerable care must be taken to ensure that theIMD and associated leads remain sterile for implantation. Once the IMDis removed from the sterile packaging, the IMD cannot be re-shelvedshould the patient not meet implantation criteria. As such, externalequipment is often substituted for making physiological measurements orperforming electrophysiological mapping. Use of external equipment forperforming testing or mapping includes certain limitations, however,since the electronics of the external equipment will generally bedifferent than the electronics of the IMD. Signals measured by externalequipment may not be the same as signals measured at the same locationby the IMD. Even minor signal differences can limit the usefulness orreliability of such measurements for the purposes of pre-implant tests.

Since IMDs tend to be costly devices, it is undesirable to open the IMDsterile packaging prior to knowing with reasonable certainty that theIMD is appropriate for the patient and that an acceptable implantationsite for the device and/or leads can be identified. Furthermore,external equipment needed for performing pre-implant testing may not bereadily available and requires extra space within the operating theater,which is often already crowded with equipment and personnel. Often aprogrammer that supports surface ECG recording in addition to receivingtelemetry signals from the IMD is needed to perform pre-implant testing.Such full-function programmers can be bulky and costly to provide to allclinical centers.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is an illustration of one type of IMD in which an embodiment ofthe invention may be implemented.

FIG. 2 is an illustration of an alternative IMD with which the inventionmay be practiced.

FIG. 3 is a functional block diagram representing components that may beincluded in an IMD electronics module along with associated memory.

FIG. 4A is a block diagram providing an overview of an IMD packagingsystem including an electrical interface according to variousembodiments of the invention.

FIG. 4B is a diagram of an IMD packaging system wherein an electricalinterface is provided in the form of a flexible circuit.

FIG. 5 is a perspective view of one type of sterilizable package thatmay be used in various embodiments of the invention.

FIG. 6A is a side cut-away view of one embodiment of a packaging systemincluding an electrical interface used for accessing IMD electronicswhile the IMD is contained within a sterile package.

FIG. 6B is a side, sectional view of an alternative embodiment ofpackaging system including a pressure generating member for promotingreliable electrical contact between an electrical interface and an IMDenclosed in a sterile package.

FIG. 6C shows a pressure generating member 121 packaged within an innertray, around an IMD and electrical interface for promoting goodelectrical contact between the IMD and electrical interface.

FIG. 7 is a top view of the packaging system shown in FIG. 6A.

FIG. 8 is a partial, side, cut-away view of an IMD packaging systemaccording to an alternative embodiment of the invention wherein anelectrical interface is formed on a substrate that includes a surface ofthe sterilizable package.

FIG. 9 is a bottom view of the inner tray lid shown in FIG. 8.

FIG. 10A is a top view of an alternative embodiment of a flexiblecircuit electrical interface formed on the inner surface of an innertray lid.

FIG. 10B is a top view of the flexible circuit shown in FIG. 10A afterfolding the flexible substrate along fold lines to provide insulation tothe exterior portions of conductors.

FIG. 10C is a top view of the electrical interface shown in FIG. 10Bfurther including elements for protecting the electrical interface.

FIG. 11 is a perspective view of an alternative embodiment of anelectrical interface.

FIG. 12 is a diagram of an alternative embodiment of an electricalinterface used for connecting to IMD electronics while the IMD is withinsterile packaging.

FIG. 13 is a partial, side cut-away view of a packaging system accordingto another embodiment of the invention.

FIG. 14 is a partial, side cut-away view of an electrical interfaceprovided with a substrate that extends along the outer surface of apackage tray lid.

FIG. 15 is a plan view of an IMD in a sterilizable package provided withan interface for accessing IMD electronics according to anotherembodiment of the invention.

FIG. 16 illustrates a bifurcated electrical interface.

DETAILED DESCRIPTION

In the following description, references are made to illustrativeembodiments for carrying out the invention. It is understood that otherembodiments may be utilized without departing from the scope of theinvention. For the purposes of illustration, various embodiments of theinvention are described herein in the context of IMDs used to monitorcardiac function. Such IMDs may or may not include cardiac stimulationtherapy delivery capabilities. Such devices include, for example,cardiac pacemakers, which may be used for delivering a wide variety ofcardiac stimulation therapies including, for example, bradycardiapacing, cardiac resynchronization therapy, extra systolic stimulation,and anti-tachycardia pacing. Such devices further includecardiovertor/defibrillators, implantable ECG recorders, and implantablehemodynamic monitors.

The scope of the invention is not limited, however, to devicesconfigured to monitor cardiac signals. Aspects of the invention may beimplemented in any IMD system in which electrical connection to the IMDelectronics, prior to removing the IMD from sterilized packaging, isdesired. Access to the IMD electronics may be desired for demonstrationpurposes, for verifying device functionality, or for performingpre-implant testing. Among the other types of IMDs in which aspects ofthe invention may be implemented are implantable drug pumps andneurostimulators, which are used for stimulating any portion of thecentral or peripheral nervous system. For example, neurostimulators maybe used for controlling pain, reducing tremor, restoring musclefunction, controlling incontinence, treating sleep apnea, treatingdigestive disorders or for vagal nerve stimulation for controllingcardiac function.

FIG. 1 is an illustration of one type of IMD in which an embodiment ofthe invention may be implemented. IMD 10 is shown as an implantable ECGrecorder, also referred to as an implantable loop recorder (ILR). IMD 10is provided with a housing 12 for enclosing an electronics module 16which controls device function and associated memory 18 for storing ECGdata. IMD 10 includes two or more electrodes 14 incorporated on IMDhousing 12 which function as subcutaneous ECG electrodes for therecordation of ECG signals by IMD 10. Electrodes 14 are coupled to theinternal electronics module 16 such that ECG signals may be sensed byelectrodes 14 and stored in memory 18, typically in a continuouslylooping manner. Examples of implantable cardiac monitoring devices thatmay be used for recording ECG data, as well as other physiological data,are generally disclosed in U.S. Pat. No. 5,987,352 (Klein et al., Nov.16, 1999), hereby incorporated herein by reference in its entirety.

It can be appreciated that the selection of an implant site for IMD 10is important in ensuring that the ECG signal strength is adequate.Typically, pre-implant mapping is performed using an external ECGmonitor connected to electrodes placed on the surface of the patient'sskin to localize a site corresponding to the strongest ECG signalstrength. Since the electrodes 14 incorporated on the IMD housing 12 arerelatively small compared to typical surface ECG electrodes, neonatal orpediatric-sized surface electrodes are commonly used to mimic the sizeand separation of the subcutaneous electrodes 14 on IMD housing 12.However, even when the subcutaneous electrode size and spacing isclosely represented by the surface electrodes used for pre-implantmapping, the electronics of the external ECG monitor may bear differentmapping results than when the ECG measurements are taken directly usingthe IMD electronics module 16.

FIG. 2 is an illustration of an alternative IMD with which the inventionmay be practiced. IMD 20 includes a housing 22 for enclosing internalelectronics 16, and a connector header 24 for receiving leads 26disposed in operative relation to a patient's heart. Leads 26 areillustrated as transvenous leads which generally carry endocardialelectrodes at or near a distal lead end. A variety of leadconfigurations are available for use with an IMD, which may include oneor more unipolar, bipolar, or multipolar leads carrying endocardial,epicardial, subcutaneous, or other types of electrodes and/or otherphysiological sensors such as blood pressure sensors, pH sensors,accelerometers, etc.

Leads 26 are each provided with a proximal connector assembly havingconnectors corresponding to each of the electrodes/sensors carried bythe individual lead. Connector header 24 includes electrical contactswhich become electrically coupled to the lead connectors when the leadconnector assembly is fully inserted in the connector header 24.Electrical contacts included in connector header 24 provide electricalconnection between the lead connector assembly and the internal IMDelectronics 16. Connection methods for connecting leads to an IMD areknown in the art. An IMD may alternatively be provided with anycombination of electrodes or sensors adapted for subcutaneous ornon-subcutaneous implantation, either on the device housing as shown inFIG. 1 or carried by leads extending from the IMD, as generallyillustrated in FIG. 2.

FIG. 3 is a functional block diagram representing components that may beincluded in an IMD electronics module along with associated memory. AnIMD, such as IMD 10 or IMD 20 shown in FIGS. 1 and 2 respectively, isgenerally provided with an electronics module 16 including timing andcontrol circuitry 32 and an operating system that may employmicroprocessor 30 or a digital state machine for timing sensing andtherapy delivery functions in accordance with a programmed operatingmode. Microprocessor 30 and associated memory 18 are coupled to thevarious components of the IMD via a data/address bus 35. If the IMD isconfigured to deliver a therapy, a therapy delivery unit 34 is providedwhich may include a pulse generator for delivering electricalstimulation or a drug reservoir and pump for delivering a drug therapy.Therapy delivery unit 34 delivers therapies as needed under the controlof timing and control 32. In the case of electrical stimulationtherapies, such as cardiac stimulation therapies, therapy delivery unit34 is typically coupled to two or more electrode terminals 15,optionally via a switch matrix 36. Switch matrix 36 may be used forselecting which electrodes and corresponding polarities are used fordelivering electrical stimulation pulses. The appropriate number ofelectrode terminals 15 is electrically coupled to electronics module 16via feedthrough according to methods known in the art. Electrodeterminals 15 may be embodied as electrodes 14 incorporated in thehousing of the IMD, as shown in FIG. 1, or contacts which becomeelectrically coupled to lead connectors as described in conjunction withFIG. 2.

Terminals 15 may also be used for coupling electrodes used for sensingelectrical signals within the body to the electronics module 16. Withregard to the cardiac monitoring IMD 10 shown in FIG. 1, electrodeterminals 15 are embodied as subcutaneous electrodes 14 to deliver ECGsignals to signal processor 38. In other embodiments, combinations ofmultiple subcutaneous and/or cardiac electrodes may be used foracquiring multiple ECG vectors using electrode terminals 15. Suchsignals may be stored in memory 18 on a continuous, periodic ortriggered basis for use in diagnosing or monitoring a disease state. Forexample, in an ILR, heart rate and/or arrhythmia information may bedetermined from stored ECG signals. In devices that include therapydelivery capabilities, such as IMD 20 of FIG. 2, sensed cardiacelectrical signals are also used for determining when an electricalstimulation therapy is needed and in controlling the timing ofstimulation pulses.

Electrodes used for sensing and electrodes used for stimulation may beselected via switch matrix 36. When used for sensing, electrodeterminals 15 are coupled to signal processing circuitry 38 via switchmatrix 36. Signal processor 38 includes sense amplifiers and may includeother signal conditioning circuitry and an analog to digital converter.Electrical signals may then be used by microprocessor 30 for detectingphysiological events, such as detecting and discriminating cardiacarrhythmias. In other embodiments, electrical signals sensed atelectrode terminals 15 may be used for measuring impedance signals formonitoring edema, respiration or heart chamber volume.

One or more physiological sensors 41 may optionally be included. Suchsensors may include pressure sensors, accelerometers, impedance sensors,flow sensors, blood chemistry sensors, activity sensors or otherphysiological sensors known for use with IMDs. Sensors 41 are coupled toelectronics module 16 via a sensor interface 40 which provides sensorsignals to signal processing circuitry 38. Sensor signals are used bymicroprocessor 30 for detecting physiological events or conditions. Forexample, an IMD may monitor heart wall motion, blood pressure, bloodchemistry, respiration, or patient activity. Monitored signals may beused for sensing the need for delivering a therapy under control of theoperating system.

The operating system includes associated memory 18 for storing a varietyof programmed-in operating mode and parameter values that are used bymicroprocessor 30. The memory 18 may also be used for storing datacompiled from sensed physiological signals and/or relating to deviceoperating history for telemetry transmission upon receipt of a retrievalor interrogation instruction. These functions and operations are knownin the art, and are generally employed to store operating commands anddata for controlling device operation and for later retrieval todiagnose device function or patient condition.

Telemetry circuitry 42 is typically provided to enable bidirectionalcommunication between the IMD and an external programmer, home monitor,patient activator, or other external device, according to methods andapparatus known in the art. Programming commands or data are transmittedduring uplink or downlink telemetry between IMD telemetry circuitry 42and external telemetry circuitry included in a programmer or monitoringunit. According to one embodiment of the invention, pre-implant testdata is obtained using a packaging system that enables connection toelectronics module 16 through a sterile IMD package. Pre-implant testdata so obtained can be transmitted in real time, or at a delayed time,to an external monitor/programmer using telemetry circuitry 42.Telemetry circuitry 42 may correspond to telemetry systems known in theart, and may be configured for long-range telemetry communication with amonitor/programmer. Long-range telemetry systems are generally disclosedin U.S. Pat. No. 6,482,154 issued to Haubrich et al., incorporatedherein by reference in its entirety.

In some embodiments, an alert unit 44 is provided for generating anaudible tone or sound. As will be described in greater detail below,electronics module 16 may be used to perform pre-implant testing using aflexible circuit or other coupling appliance for connecting externalelectrodes to terminals 15 without compromising the sterility of IMDwithin a sterile package. Microprocessor 30 may process signals receivedat terminals 15 for determining if implantation criteria are met or foridentifying an optimal implantation location or orientation. Alert unit44 may be used to generate an audible tone or sound to indicate to aclinician that a particular test location or orientation meets or doesnot meet implant criteria or acceptable signal quality.

It is recognized that the overall complexity of electronics module 16and other IMD components may vary depending on the functionalityprovided by the IMD. Functional units may be added or removed from theblock diagram represented in FIG. 3 according to a particularapplication. For example, IMD 10 shown in FIG. 1 may be used for ECGmonitoring without therapy delivery capabilities in which caseelectronics module 16 is provided without therapy delivery unit 34. Inother embodiments, a leadless IMD incorporating electrodes in the IMDhousing may include pacing and/or cardioversion/defibrillationcapabilities in which case therapy delivery unit 34 would include alow-voltage pulse generator and/or high-voltage capacitors withassociated capacitor charging and high-voltage output circuitry as isknown in the art.

FIG. 4A is a block diagram providing an overview of an IMD packagingsystem according to various embodiments of the invention. The packagingsystem 62 includes a sterilizable package 60 for containing an IMD 10.Packaging system 62 further includes an electrical interface 50 thatallows electrodes or other sensors placed on or in a patient 66 to becoupled to electronics module 16 while IMD 10 remains with sterilizablepackage 60, without compromising the sterility of IMD 10.

Electrical interface 50 includes patient terminals 54, signal/conductiontransmission 56, and package contacts 52. Patient terminals 54 may be inthe form of electrodes adapted for placement directly on or in patient66. Alternatively, patient terminals 54 may be provided as connectors,such as snaps or clips, onto which electrodes or sensors placed on or inpatient 66 may be attached using a cable, extension or lead. One or morepackage contacts 52 are electrically coupled to IMD electrode terminals15 (or sensor terminals 41) included in IMD 10 and thereby electricallycoupled to electronics module 16. As described previously, IMD electrodeterminals 15 may be embodied as electrodes formed in or on the housingof IMD 10. IMD electrode terminals 15 may alternatively be embodied ascontacts used for electrically coupling lead-based electrodes and/orsensors to IMD 10. The number of package contacts and correspondingpatient terminals provided will depend on the application and maycorrespond to the total number of electrodes and sensors used by the IMDor a subset of electrodes and sensors used by the IMD.

Electrical interface 50 includes signal conduction/transmission 56 whichacts to convey signals received from the patient at patient terminals 54to package contacts 52, across a sterile barrier 61 of package 60.Signal conduction/transmission 53, generally referred to as “conductorcircuit” hereafter, may include conductors in the form of wires, foils,conductive tape, film or ink. However, it is recognized that conductorcircuit 53 is not limited to include only conductive elements. Invarious embodiments, conductor circuit 53 may include inductiveelements, capacitive elements, antennas, optical fibers, or any otherelements appropriate for conducting or transmitting a physiologicalsignal received at patient terminals 54 to package contacts 52.Alternatively, signals may be transmitted from IMD electronics module 16to patient 66 using electrical interface 50. Depending on the type ofsensors used by IMD 10, electrical excitation signals may be requiredand transmitted to a sensor operatively positioned in patient 66 viaelectrical interface 50. During some pre-implant testing, system testsor demonstration procedures, electrical pulses, for example stimulationpulses, may be transmitted from electronics module 16 to patientterminals 54.

FIG. 4B is a diagram of an implantable medical device packaging systemwherein electrical interface 50 is provided in the form of a flexiblecircuit that allows access to the IMD electronics module 16 while theIMD 10 is enclosed in a sterilizable package 60. The packaging systemincludes electrical interface 50 extending from outside sterilizablepackage 60 to inside sterilizable package 60. Electrical interface 50includes one or more package contacts 52 each coupled to individualconductors 56 included in conductor circuit 53, and one or more patientterminals 54. Each of conductors 56 extend across sterile barrier 61,between an interior end 59 coupled to a package contact 52 and anexterior end 57 coupled to a patient terminal 54.

In the embodiment shown, package contact 52 is disposed over asubcutaneous electrode 14 located on IMD housing 12 while the IMDremains in package 60. Package contact 52 makes electrical connectionwith electrode 14 thereby allowing electrical connection to theelectronics contained in IMD 10 using patient terminal 54, locatedoutside of sterilizable package 60. In various embodiments, packagecontact 52 may be adapted for electrical coupling to any electrode orany electrode/sensor terminal or contact incorporated in or on IMD 10.

Sterilizable package 60 is provided as a tray, pouch or other containerfor enclosing and maintaining sterility of IMD 10. Sterilizable package60 is typically sealed closed after receiving IMD 10 to form sterilebarrier 61 and submitted to a sterilization method appropriate for theparticular IMD contained therein, e.g., steam, gas, or ultrasonicsterilization. Electrical interface 50 conveys electrical signalsreceived at patient terminals 54 across sterile barrier 61 withoutcompromising the integrity of the sealed package 60 or the sterility ofthe IMD 10.

Electrical interface 50 may be fabricated as a flexible circuit usingconductive ink (e.g., silver-silver chloride ink or a carbon-based ink)printed on a flexible, insulative substrate 55 to form conductors 56,package contacts 52 and patient contacts 54. Alternatively, any ofconductors 56, package contacts 52 and patient contacts 54 may be formedby laminating or adhering electrically conductive materials in the formof wires, foils, film, or tape, onto flexible substrate 55. As will bedescribed in greater detail below, in some embodiments flexiblesubstrate 55 includes a portion of sterilizable package 60 whereinelectrical interface 50 is formed on a surface of package 60.

Patient terminals 54 may be provided for direct placement on a patient'sskin. Electrical body signals may then be provided to IMD 10 viaelectrical interface 50. Electrical interface 50 is provided with a“neck” 64 along which conductors 56 extend. Neck 64 may be provided withany length to facilitate unencumbered placement of patient terminals 54on a patient. Alternatively, patient terminals 54 may be embodied ascoupling terminals or contacts to which electrode cables or extensions80 may be attached to thereby allow greater maneuverability andflexibility during pre-implant testing, without patient-to-IMD distancelimitations. Electrode extensions 80 may be standard surface electrodecables carrying surface electrodes 82, which may be standard “off-theshelf” electrodes, adapted for placement on a patient's skin.

Patient terminals 54 may alternatively be adapted for electricalcoupling to patient leads or lead extensions. For example, extensions 80may be provided with snaps, alligator clips, manufacturer-providedconnectors, or other electrical connectors for facilitating electricalconnection to patient terminals 54 at one end of an extension 80 and toa connector assembly of an implanted lead at the other end of anextension 80. Extensions 80 may be provided in a sterile condition toallow connection to implanted sterile leads. It is recognized thatnumerous configurations may be used for connecting patient terminals 54to a patient, either directly or indirectly using extensions and/orleads, and such embodiments may include any number of electrodes and/orsensors positioned on or in the patient.

A template 84 may be provided for guiding placement of surfaceelectrodes 82 to correspond to the separation distance of IMD electrodes14. Alternatively, electrode extensions 80 and surface electrodes 82 maybe custom components, provided with template 84 for mimicking the sizeand separation of IMD electrodes 14. Patient terminals 54 may beprovided as snaps, clips, or any other mechanism for mechanically andelectrically coupling electrode extensions 80. Template 84 may includelabeling to indicate which patient terminals 54 correspond to which IMDelectrode terminals 15 and/or sensor terminals 41.

During pre-implant testing, signals obtained during placement of patientterminals 54 at different body locations and orientations may be storedand analyzed by IMD 10 for determining an optimal implant location.Alternatively or additionally, IMD 10 may transmit signals receivedusing electrical interface 50 to an external programmer/monitor 70 via atelemetry connection 71.

External programmer/monitor 70 may correspond generally toprogrammer/monitors known in the art and typically includes telemetrycircuitry 72, a microprocessor-based control system 74, a display 76,and a user-interface 78, which may be embodied as a graphical userinterface. Display 76 may be in the form of an LCD screen or othergraphical or video display that allows a clinician to observe displayedsignal data, for example ECG signals, while patient terminals 54 arepositioned at different body locations or orientations. The clinicianmay manually select an optimal implant location based on observed data.

Alternatively, external programmer/monitor 70 or IMD 10 may analyzereceived signals using a programmed signal evaluation routine andautomatically recommend an implant site or at least indicate when alocation or orientation meets signal quality or other implant criteria.Such information can be displayed graphically or using text messages ondisplay 76. Alternatively, display 76 may be embodied as an LED displaywhich indicates through color or number of LEDs illuminated acceptableon unacceptable signal quality. In yet another embodiment, display 76may include a speaker for broadcasting sound messages indicatingacceptable or unacceptable signal quality. As described previously,alert circuitry 44 may generate a signal indicating acceptable orunacceptable signal quality. A signal evaluation routine may determinesignal features, signal-to-noise ratio, or other signal characteristicsfor determining if the signal quality meets predefined acceptancecriteria.

Display 76 may further be used to prompt a clinician or other user tomove patient terminals 54 to a number of body locations or orientationswhile IMD 10 and/or external monitor/programmer 70 collects signal datacorresponding to each location. The clinician or other user may use userinterface 78 to indicate to IMD 10 or external monitor/programmer 70when patient terminals 54 are being moved to a new location and therebyindicate when IMD 10 or external monitor/programmer 70 should begin anew signal evaluation routine. When multiple electrodes or sensors areavailable and coupled simultaneously to IMD 10 using patient terminals54, the IMD 10 may select different sensing vectors using switchingcircuitry 36 (shown in FIG. 3), either automatically or in response toprogrammed-in commands.

External programmer/monitor 70 may vary in functionality and complexityin different embodiments. For example, in some embodiments, externalprogrammer/monitor 70 may receive signal data using telemetry circuit72, process signal data using microprocessor 74, and display pre-implanttest results on display 76. External programmer/monitor 70 may include adata storage module for printing or storing received data and/or testresults electronically. In other embodiments, externalprogrammer/monitor 70 may be interfaced with a monitoring device 94 usedfor displaying and/or storing signal data obtained using electricalinterface 50.

In still other embodiments, external programmer/monitor 70 may serve asa communication conduit between IMD 10 and a computerized database 90.Database 90 may be a web-based patient management system or implementedon a personal computer. Database 90 is coupled to a communicationnetwork 92, which may be a wireless network, enabling communicationbetween database 90 and external programmer/monitor 70. Signal datareceived by external programmer/monitor 70 is transmitted to database 90via communication network 92. As such, signals obtained using electricalinterface 50, or test results based on such signals, may be transmitteddirectly to database 90 for further analysis and/or viewing by a user.Database 90 may be accessible on a local or remote computer, allowingpre-implant testing to be performed in a time and place independentmanner. Database 90 and external programmer/monitor 70 may be providedaccording to known patient management systems, such as those generallydisclosed in U.S. Pat. No. 6,250,309 (Krichen, et al.) and U.S. Pat. No.6,622,045 (Snell et al.), both of which patents are incorporated hereinby reference in their entirety.

FIG. 5 is a perspective view of one type of sterilizable package thatmay be used in various embodiments of the invention. Package 60 includesa tray 104, typically provided with a cavity 106 formed to match thecontours of an IMD to be placed therein. Package tray 104 has an innersurface 110 and an outer surface 111 which, in addition to cavity 106,may form other cavities or recesses for containing accessories, tools orother components packaged with the IMD for use during implantationprocedures. Tray 104 is fabricated using thermoforming, injectionmolding or other appropriate processing of a material that withstandssterilization procedures used to sterilize the IMD contained therein andacts as a sterile barrier there after. Packaging tray 104 is commonlyfabricated from high-density polyethylene.

Tray 104 includes a seal area 108 along inner surface 110 onto which atray lid 102 is sealed after the IMD and any other package contents areplaced in tray 104. Tray lid 102 includes an outer surface 105 and aninner surface 103 and is commonly fabricated from coated paper or ahigh-density woven or non-woven polymer material. Tray lid 102 and tray104 are typically sealed together along seal area 108 using anappropriate adhesive for forming a reliable sterile barrier. Afterundergoing sterilization, package 60 is placed in any desired outerpackaging, which is typically a box or carton provided with appropriatelabeling. In some embodiments, the packaging system may include an outertray and outer tray lid for containing inner tray 104 sealed with innertray lid 102. Inner tray 104 may be sterilized within the outer tray,and the outer tray is placed in the desired outer packaging.

FIG. 6A is a side cut-away view of one embodiment of a packaging systemincluding an electrical interface used for accessing IMD electronicswhile the IMD is contained within a sterile package 60. Sterile package60 includes an inner tray 104 and outer tray 114. IMD 10 rests in cavity106 of inner tray 104. An electrical interface 50 in the form of aflexible circuit 50 is placed over IMD 10 such that package contact 52is electrically coupled to IMD electrode 14. Inner tray 104 is sealedclosed with inner tray lid 102 along seal area 108. Inner tray 104 isplaced within a tray cavity 116 of outer tray 114. Outer tray 114 issealed closed with outer tray lid 112 along outer tray seal area 118.The neck 64 of electrical interface 50 is sealed between inner tray lid102 and inner tray 104 and between outer tray lid 112 and outer tray 114and extends outside of package 60. Patient terminals 54 are located atthe exterior ends 57 of conductors 56 extending along neck 64. Patientterminals 54 are thus available outside of package 60 for use incoupling a patient to the electronics module contained within IMD 10,without compromising the sterility of IMD 10 within package 60.

The depth of IMD cavity 106 in inner tray 104 is dimensionedappropriately to cause electrode 14 to come into contact with packagecontact 52 when the packaging system 62 is assembled. To promotereliable coupling between package contact 52 and IMD electrode 14, thethickness 115 of substrate 55, at least in the area of package contact52, is provided to create pressure between contact 52 and IMD electrode14. Package contacts 52 may be formed as blisters or buttons, having agenerally hemispherical shape, for example, which protrudes fromflexible circuit substrate 55 to thereby promote reliable electricalcontact with IMD electrodes 14.

Additionally or alternatively, a compressible element 120 may beincluded or incorporated in inner tray 104. Physical contact betweenpackage contact 52 and IMD electrode 14 should be adequate to create anelectrical connection between contact 52 and electrode 14 withoutcausing mechanical damage to electrode 14. As shown, compressibleelement 120, which may be embodied as a compressed foam member, isplaced between the inner surface 110 of inner tray 104 and IMD 10.Compressible element 120 generates pressure between IMD electrode 14 andpackage contact 52 to promote reliable electrical contact there between.Compressible element 120 could alternatively be positioned between theinner surface 103 of inner tray lid 102 and electrical interface 50 oralong the outer surface 105 of inner tray lid 102, between inner traylid 102 and outer tray lid 112. Compressible element 120 mayalternatively be enclosed in an outer carton containing package 60 andpositioned to generate pressure in the area of package contact 52 andIMD electrode 14.

FIG. 6B is a side, sectional view of an alternative embodiment ofpackaging system including a pressure generating member 121 forpromoting reliable electrical contact between electrical interface 50and IMD 10 enclosed in sterile package 60. In FIG. 6B, pressuregenerating member 121 is provided as a generally U-shaped clip having aclosed side 119 and an open side 117. Pressure generating member 121 isadapted for positioning around the outside of outer tray 114 and outertray lid 118 to generate positive pressure in the area of packagecontact 52 and IMD electrode 14 to promote good electrical contact therebetween.

Pressure generating member 121 may be packaged in an outer carton alongwith sterile package 60 and placed in the position shown in FIG. 6B by auser as needed at the time of testing. Alternatively, pressuregenerating member 121 may be packaged with sterile package 60 alreadypositioned around sterile package 60 as shown in FIG. 6B. In otherembodiments, pressure generating member 121 may be positioned withinouter tray 114, around inner tray 104 and inner tray lid 102 to promotegood electrical contact between package contact 52 and IMD electrode 14.Pressure generating member 121 could alternatively be packaged withininner tray 104, around IMD 10 and electrical interface 50 as shown inFIG. 6C. In this embodiment, electrical interface 50 would not be sealedalong its entire periphery between inner tray lid 102 and inner tray 104in order to allow pressure generating member 121 to be fitted over oneside or end of electrical interface 50 as shown. Pressure generatingmember 121 may also act to stabilize the position of electricalinterface 50 relative to IMD 10.

Pressure generating member 121 may be formed of a relatively rigidpolymeric or metal material which may be flexible along closed side 119to allow open side 117 to be opened wider to enable member 121 to beslid over the outside of sterile package 60 (or inner tray 104 and traylid 102 or IMD 10 and electrical interface 50). It is recognized thatpressure-generating member 121 may be provided in numerousconfigurations for promoting good contact between electrical interface50 and IMD 10. For example, pressure generating member 121 mayalternatively be formed having a “clam-shell” shape, having a hinged orspring-loaded side or sides, or having latching mechanisms. Pressuregenerating member 121 may be used alone or in combination withcompressible element 120. Pressure generating member 121 and/orcompressible element 120 may be designed to create a predetermined,constant pressure at the contact point between IMD 10 and electricalinterface 50.

FIG. 7 is a top view of the packaging system shown in FIG. 6A.Electrical interface 50 includes a flexible substrate 55 that may beformed to match the outer contours of the inner tray 104. Substrate 55becomes sealed between inner tray 104 and inner tray lid 102 (shown inFIG. 6A) along the entire seal area 108. Providing substrate 55 alongthe entire seal area 108 may prevent thickness differentials along sealarea 108 that might otherwise leave discreet openings along the sealarea 108 which could lead to contamination of the inner tray contents.Alternatively substrate 55 may be formed such that substrate 55 issealed between inner tray 104 and inner tray lid 102 along any portionof seal area 108, as long as a reliable seal is formed between tray 104and tray lid 102 for maintaining sterility of IMD 10 and any otherpackaged components. Generally, substrate 55 will be sealed between tray104 and lid 102 at least along the area where neck 64 of electricalinterface 50 traverses inner seal area 108

Conductors 56 may be insulated by a dielectric layer 124 formed overconductors 56. Dielectric layer 124 may additionally extend over anyportion or all of substrate 55, while leaving package contacts 52 andpatient contacts 54 exposed. Dielectric layer 124 may extend over theentire inner tray seal area 108 to promote a uniform, reliable seal.Dielectric layer 124 may be formed from any dielectric polymericmaterial including polyesters, ethylene-vinyl acetate copolymers,terpolymers such as acrylonitrile-butadiene styrene, or polyvinylchloride and its copolymers. Alternatively, conductor circuit 53 mayinclude shielded conductors and contacts to protect the IMD and/orpatient from electrical noise.

The exterior end of substrate 55 may be formed into a template 84 uponwhich patient contacts 54 are mounted. Template 84 corresponds to thesize and shape of IMD 10 with patient contacts 54 sized and spacedrelative to one another to mimic the size and spacing of IMD electrodes14. Once an optimal implant site is identified through pre-implanttesting, the site may be marked or traced using template 84. Template 84may be provided having stencil openings 122 to facilitate marking aselected implant site on a patient.

In FIG. 7, conductor circuit 53 is shown to include LEDs 128 along eachconductor 56. LEDs 128 may be used to indicate that an electricalcircuit has been completed and signals received at patient terminals 54are being conducted to IMD 10. In some embodiments, the IMD 10 maytransmit signals to patient terminals 54, such as sensor excitationsignals or electrical stimulation pulses. As such, LEDs 128 may be usedto indicate that electrical signals from IMD 10 are being conducted topatient terminals 54.

After completing pre-implant testing, the outer tray lid may be removedfrom outer tray 114. Neck 64 of electrical interface 50 may be providedwith notches or perforations 126 to facilitate tearing of the electricalinterface 50 just outside of inner tray 104. Tearing of electricalinterface 50 allows inner tray 104 to be removed from outer tray 114without hindrance due to attachment of electrical interface 50 to outertray 114 along outer tray seal area 118.

FIG. 8 is a partial, side, cut-away view of an IMD packaging systemaccording to an alternative embodiment of the invention wherein anelectrical interface is formed on a substrate that includes a surface ofthe sterilizable package. In this example, inner surface 103 of innertray lid 102 serves as a substrate for electrical interface 50. In thisembodiment, conductors 56 and package contacts 52 are shown printed orlaminated to inner surface 103 of inner tray lid 102. Conductors 56 maybe insulated by a dielectric layer 124.

FIG. 9 is a bottom view of the inner tray lid shown in FIG. 8. Tray lid102 is provided with a shape that mates with the seal area 108 of innertray 104 (shown in FIG. 5) and serves as a substrate for electricalinterface 50. Inner tray lid 102 is formed with neck 64 extending therefrom with patient terminals 54 coupled to the exterior ends 57 ofconductors 56. Inner tray lid 102 may be fabricated from paper or ahigh-density, woven or non-woven polymer, such as a high-densitypolyethylene. Conductors 56, patient terminals 54 and package contacts52 may be printed on inner tray lid 102 using a conductive ink or may beprovided as foil, tape, film conductive material laminated to tray lid102. In some embodiments, the inner surface 103 of inner tray lid 102,or any other substrate onto which electrical interface 50 is formed, maybe bonded or treated with a coating to promote good adhesion of theconductive material on the substrate. The tray lid 102 is coated with anadhesive along seal area 108 for sealing lid 102 to inner tray 104.

FIG. 10A is a top view of an alternative embodiment of an electricalinterface formed on the inner surface of an inner tray lid. Thesubstrate 55 is formed with lateral flaps 130 along neck 64 which can befolded along fold lines 132 over elongated conductors 56 therebyproviding insulation to conductors 56. Lateral flaps 130 are formedhaving patient electrode windows 134 such that when lateral flaps 130are folded along fold lines 132, patient electrodes are exposed and notinsulated by lateral flaps 130. A portion 136 of neck 64 correspondingto the seal area 108 of an outer tray, when used, is provided withoutlateral flaps 130. The portions of conductors 56 that become enclosedwithin inner tray 104, inner tray seal area 108, and outer tray sealarea 118 may not need to be insulated and may remain exposed. FIG. 10Bis a top view of the electrical interface shown in FIG. 10A afterfolding substrate 55 along fold lines 132 to provide insulation to theportions of conductors 56 which will be located outside of an outertray.

FIG. 10C is a top view of the electrical interface shown in FIG. 10Bfurther including elements for protecting the electrical interface. Insome embodiments, a removable patient terminal insulator 137 may beprovided for protecting patient terminals 54 from mechanical damage orwear and/or to prevent unwanted electrical signals to be coupled throughto the IMD electronics via terminals 54. Removable patient terminalinsulator 137 may be provided, for example, in the form of a removabletape that is pulled away to expose patient terminals at the time ofpre-implant testing or other use of electrical interface 50. Patientterminal insulator 137 may be provided as a replaceable element suchthat after testing is completed, insulator 137 may be placed back overpatient terminals 54.

A removable short circuit element 138 may be provided across conductors56 so as to prevent unwanted electrical signals from reaching the IMDelectronics. Short circuit element 138 may be provided, for example, asa strip of conductive tape extending across conductors 56 which can beremoved at the appropriate time to enable pre-implant testing or otheruse of electrical interface 50. Short circuit element 138 may beprovided as a replaceable element such that after testing is completed,short circuit element 138 can be put back in place to create a shortacross conductors 56.

FIG. 11 is a perspective view of an alternative embodiment of anelectrical interface. Substrate 55 is provided with a single lateralflap 130 along neck 64 sized to cover and insulate conductors 56 afterfolding lateral flap 130 along folding line 132. Windows 134 areprovided in lateral flap 130 such that patient terminals 54 remainexposed after folding lateral flap 130 over conductors 56. Lateralflap(s) 130 as shown in FIG. 10B and 11 may be laminated to neck 64 orsealed to neck 64 using the same method for sealing inner tray lid 102to an inner tray. In FIG. 11, patient terminals 54 are shown to includeconnection members 135, which may be in the form of snaps or clips, tofacilitate connection of electrode leads or cable extensions asdescribed previously.

While FIGS. 8 through 11 depict electrical interface 50 formed on aninner surface of inner tray lid 102, it is recognized that electricalinterface 50 may be formed on any inner surface of package 60 so long aspackage contacts 52 become electrically coupled to IMD electrodes 14.For example, in some embodiments, the IMD may be configured andcontained within an inner tray such that contact with an electrodeterminal 15 (shown in FIG. 4A) is best made from an inner surface of theinner tray rather than the tray lid. In such a configuration, packagecontact 52 and a portion of the conductor circuit 53 may be formed on aninner surface of the inner tray instead of the tray lid.

FIG. 12 is a diagram of an alternative embodiment of an electricalinterface used for connecting to IMD electronics while the IMD is withinsterile packaging. Conductor circuit 53 includes conductors 56 andcapacitive elements 140 used to conduct signals across seal area 108 ofpackage 60. It is recognized that conductive circuit 53 may include anycircuitry used to convey signals sensed using patient terminals 54 topackage contacts 52. A capacitive element 140 may be used to conductsignals across a sterile barrier of package 60. The inner tray wall orthe seal area 108 may serve as a dielectric in the capacitive element140. A conductor circuit 53 including a capacitive element 140 mayprotect the patient and/or IMD from noise or signal baseline variationthat may be induced on conductors 56.

FIG. 13 is a partial, side cut-away view of a packaging system accordingto another embodiment of the invention. Package 60 includes sterilizableinner tray 104 containing IMD 10 having subcutaneous electrode 14. Innertray 104 is sealed closed along seal area 108 with tray lid 102. Traylid 102 serves as the substrate for electrical interface 50 includingpackage contact 52 positioned to provide electrical contact withelectrode 14. Electrical interface 50 further includes elongatedconductors 56 as shown previously extending to patient terminal 54.Electrical interface 50 is shown in a folded arrangement over an outertray lid 112 sealed to outer tray 114, containing inner tray 104. Anouter carton 150 is provided for containing outer tray 114 andelectrical interface 50.

A strain relief member 165 is shown in FIG. 13 extending from neck 64 toan outer surface of outer tray 114. Strain relief member 165 may becoupled to any portion of package 60 to provide strain relief to theportion of neck 64 crossing seal areas 118 and 108. Strain relief member165 may prevent inadvertent breach of the outer tray seal or inner trayseal when patient terminals 54 are being attached or repositioned on apatient.

Outer carton 150 has an inner surface 154 and an outer surface 152 whichform a recess 156 in which a carton contact 160 is mounted on acompressible member 162. When carton contact 160 is pressed down, cartoncontact 160 makes electrical contact with patient terminal 54. Cartoncontact 160 may be provided with a snap or clip member to facilitateattaching an external electrode extension or cable. Connection to theelectronics within IMD 10 is thereby made possible via carton electrode160 and electrical interface 50 while IMD 10 remains inside sterilizedinner tray 104, outer tray 114 and outer carton 150. It is recognizedthat in various embodiments, other signal conveying elements may beadded to or substituted for carton electrode 160, such as capacitiveelements, inductive elements, optical fibers, or antennas.

Carton 150 may be formed with a closing member 158, such as a closableflap or resealable tape that can be closed over recess 156 to protectcarton electrode 160. It is recognized that numerous configurations maybe conceived for incorporating a carton electrode 160 in outer carton150. For example, in other embodiments, carton electrode 160 may belocated along outer surface 152 extending through to inner surface 154without being positioned in a recess 156. It is further recognized thata removable insulating layer may be provided over carton electrode 160.In some embodiments, compression member 162 may not be provided, and thenormal position of carton contact 160 may be in electrical contact withpatient terminal 54. An insulating material over carton contact 160 mayor may not be used.

FIG. 14 is a partial, side cut-away view of an electrical interface 50provided with a substrate 55 that extends along the outer surface 105 oftray lid 102. Electrical interface 50 includes a package contact 52formed extending through tray lid 102 to make electrical contact withIMD subcutaneous electrode 14. In an alternative embodiment, a separatesubstrate 55 is not used and electrical interface 50 is formed on theouter surface 105 of tray lid 102. Conductor 56 would extend along traylid outer surface 105 to package contact 52 which would extend throughtray lid 102 to make electrical contact with IMD electrode 14.Alternatively, elongated conductor 56 may extend through tray lid 102.Conductor 56 may be provided as a conductive wire, foil, or film thatpenetrates tray lid 102 or may include an capacitive or inductiveelement for conveying current across tray lid 102. It is recognized thatin various embodiments, any element of electrical interface 50 mayextend across a sterile barrier, i.e., from an outer surface to an innersurface of a sterilizable IMD package, along any portion of the packageand is not limited to extending across a seal area of the package.

Furthermore, the electrical interface 50 may be formed on a substrateextending along any outer or inner surface of the sterilizable IMDpackage, including an outer or inner surface of any tray, tray lid,pouch or other sterilizable IMD package. Alternatively, electricalinterface 50 may be fabricated using a separate substrate 55, whichlikewise may extend along any outer or inner surface of the sterilizableIMD package. The exact configuration of electrical interface 50 withrespect to the IMD package 60 may vary from embodiment to embodimentdepending on the orientation of the IMD within the package and theresulting location of IMD electrodes or electrode terminals with whichpackage contact(s) 52 are to be electrically coupled.

FIG. 15 is a plan view of an IMD in a sterilizable package provided withan electrical interface for accessing IMD electronics according toanother embodiment of the invention. Some IMDs may be used inconjunction with electrodes carried by leads extending from the IMDrather than being incorporated on the IMD housing. IMD 20 is shownhaving connector header 24 provided with a connector bore 200 adaptedfor receiving a connector assembly of a lead carrying one or moreelectrodes or other sensors. Connector header and lead connectorassembly configurations are known in the art. In the example shown,connector bore 200 is provided with contacts 202 and 204 for couplingwith connectors included on a lead connector assembly.

To facilitate electrical connection to electrical interface 50, IMD 20may be packaged within sterilizable package 60 with a connectorappliance 210 inserted into connector bore 200. Connector appliance 210is provided with a connector assembly 212 adapted for insertion intoconnector bore 200. Connector assembly 212 includes two connectors 214and 215 separated by an insulating segment 216. Connectors 214 and 215align with and become electrically coupled to contacts 202 and 204 whenconnector assembly 212 is fully inserted in connector bore 200.Connector assembly 212 of connector appliance 210 generally correspondsto a connector assembly provided on a lead intended for use with IMD 20.Connector appliance 210 is provided with electrode contacts 220 whichare separately coupled to each of connectors 214 and 215 by conductors217 extending through appliance 210. Package contacts 52 included onelectrical interface 50 are positioned over electrode contacts 220 suchthat patient terminals 54, located outside of package 60, can be coupledto the electronics included in IMD 20 via connector appliance 210.Alternatively, conductors 217 may extend along a substrate to theoutside of package 60 directly to patient terminals 54, without the useof package contacts 52.

Patient terminals 54 may be positioned on or in a patient or coupled toelectrodes or any other physiological sensors positioned on or in apatient via appropriate leads or extension cables. As such, electricalinterface 50 may be used to access IMD electronics included in an IMDhaving a connector header 24 with the use of a connector appliance 210.

FIG. 16 illustrates a bifurcated electrical interface. In someembodiments, two or more electrodes carried by branching or separateleads may be placed independently of each other. An electrical interface50 may be provided with a bifurcation 230 such that patient terminals 54may be placed at separate, spaced apart locations. It is recognized thatsubstrate 55 may be provided with numerous shapes or configurations forallowing placement of patient terminals 54 during pre-implant testing inany appropriate manner that mimics placement of the actual electrodes tobe used in conjunction with the IMD. Alternatively, patient terminals 54may be connected to separate electrode extensions that allowunencumbered placement of electrodes on the patient during pre-implanttesting, as described previously.

For the sake of illustration, various embodiments described herein havegenerally related to an electrical interface that allows connection toIMD electronics for pre-implant testing relating to optimizingsubcutaneous electrode placement. However, it is recognized that anelectrical interface used to access the electronics within an IMD stillcontained in a sterile package may be designed to mimicelectrodes/sensors adapted for other implant locations, e.g.,epicardial, endocardial, sub-muscular, or otherwise. As such,embodiments that include using an electrical interface for testingnon-subcutaneous implant locations of an IMD or electrodes/sensors areincluded in the scope of the invention. Pre-implant testing using theinterface may be performed to determine if the patient meets implantcriteria and/or selecting an optimal implant site.

Various embodiments of the electrical interface 50 shown in FIG. 4A havebeen described primarily in the context of an interface used to coupleelectrodes, for example ECG electrodes, to an IMD electronics moduleacross a sterile barrier. However, the electrical interface 50 may beused to couple any type and number of electrodes and/or sensors to theIMD electronics. Furthermore, electrical interface 50 may be used forpurposes other than pre-implant testing. Electrical interface 50 may beused, for example, for performing IMD system tests or for demonstrationpurposes.

Packaging systems having an interface that allows access to IMDelectronics across a sterile barrier have been presented in theforegoing description with reference to specific embodiments. It isappreciated that various modifications to the referenced embodiments maybe made without departing from the scope of the invention as set forthin the following claims.

1. A system, comprising: a sterilized package; and an implantablemedical device (IMD) placed inside the sterilized package, the IMDhaving a housing with two or more subcutaneous electrodes positioned onan exterior surface of the housing and spaced from one another by afirst distance; wherein the sterilized package comprises: a. twoelectrodes adapted for placement directly on a patient and spaced fromone another by the first difference; and b. means for conveying aphysiological signal from the electrodes to the subcutaneous electrodeson the implantable medical device housing within the sterilized packagewithout compromising sterility of the implantable medical device.
 2. Thesystem of claim 1 wherein the conveying means includes any of: aninductive element, a capacitive element, an antenna, and an opticalfiber.
 3. The system of claim 1 wherein the conveying means includes aflexible substrate and, disposed on the flexible substrate, any of:conductive ink, conductive foil, conductive film, and conductive tape.4. The system of claim 1 further including means for transmittingsignals received by the implantable medical device from the conveyingmeans to an external device.
 5. The system of claim 1 further including:a computerized database; a communication network coupled to thedatabase; means for transmitting data from the implantable medicaldevice to the database via the communication network.
 6. The system ofclaim 1 wherein further including means for processing signals receivedby the implantable medical device using the conveying means.
 7. Thesystem of claim 6 wherein the implantable medical device furtherincludes means for generating a signal corresponding to signals receivedby the implantable medical device using the conveying means.
 8. Thesystem of claim 1 wherein the sterilizable package includes an innersurface and an outer surface and wherein the conveying means is formedon a portion of any of: the inner surface and the outer surface.
 9. Thesystem of claim 1 wherein the sterilized package includes a device trayand a tray lid sealed to the device tray.
 10. The system of claim 1further including means for generating pressure for promoting electricalcontact between the conveying means and the electrodes on the housing ofthe implantable medical device.
 11. The system of claim 1 wherein theconveying means includes a template corresponding to the shape of theimplantable medical device.
 12. The system of claim 11 wherein thetemplate includes means for facilitating marking of a selected implantarrangement.
 13. The system of claim 1 wherein the conveying meansincludes a means for insulating any portion of the conveying means. 14.The system of claim 1 wherein the conveying means includes means forcreating a short circuit across the conveying means for protecting theimplantable medical device from electrical signals when the conveyingmeans is not in use.
 15. The system of claim 1 wherein the conveyingmeans includes means for relieving mechanical strain across theconveying means.
 16. The system of claim 1 further including an outercarton containing the sterilized package and means for electricallycoupling to the conveying means from outside of the outer carton. 17.The system of claim 1 wherein the conveying means includes means forindicating electrical signal conduction by the conveying means.